Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-13

Clinical Trial Update: Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety [Phase 1, Phase 2]

View source ↗

Summary

This document provides an update on Phase 1 and Phase 2 trials evaluating psilocybin for anxiety in patients with advanced-stage cancer, noting completion of th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psilocybin (psilocybin)

Snippet

Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Conditions: Anxiety | Phase 1, Phase 2 | Status: COMPLETED